CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells
2015
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells Chihiro Morishima, Douglas G McNeel, Manish R Patel, Holbrook E Kohrt, Thomas A Waldmann, John A Thompson, Kevin C Conlon, Paul M Sondel, Heather A Wakelee, Minjun C Apodaca, Steven P Fling, Mary L Disis, Stephen P Creekmore, Jeffrey S Miller
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI